Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
These approvals mark significant progress for Venus Remedies in expanding its market presence
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
To create leading company developing medicines targeting metalloenzymes
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
Subscribe To Our Newsletter & Stay Updated